Doyle Mittie Insider Profile
4 Followers
Doyle Mittie, Director at Dice Therapeutics, holds ― shares in Dice Therapeutics (Ticker: DICE), holds 3.62K shares in Avalo Therapeutics (Ticker: AVTX), holds ― shares in Cullinan Management (Ticker: CGEM). Most recently, Doyle Mittie ― shares of Dice Therapeutics on ― for an estimated value of ―.
Doyle Mittie Dice Therapeutics (DICE)Director
Dice Therapeutics (DICE)
Director
Not Ranked
Doyle Mittie has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Doyle Mittie holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Doyle Mittie
Doyle Mittie's Trading History
Dice Therapeutics
―
―
―
―
Avalo Therapeutics
Apr 03, 2026
CMO
Uninformative Buy
5.46K
$58.93K
Cullinan Management
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Doyle Mittie's performance on stock
You May Also Like
Doyle Mittie insider profile FAQ
What is the percentage of profitable transactions made by Doyle Mittie?
The percentage of profitable transactions made by Doyle Mittie is ―.
What is the average return per transaction made by Doyle Mittie?
The average return per transaction made by Doyle Mittie is ―.
What stocks does Doyle Mittie hold?
Doyle Mittie holds: DICE, AVTX, CGEM stocks.
What was Doyle Mittie’s latest transaction?
Doyle Mittie latest transaction was an Uninformative Buy of ―.
What was Doyle Mittie's most profitable transaction?
Doyle Mittie’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Doyle Mittie's role in Dice Therapeutics?
Doyle Mittie's role in Dice Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.